http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0630254-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2011643ef116d936ee27164139c83c4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 |
| filingDate | 1993-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e289bf7cc74491990c71cb6c798d509 |
| publicationDate | 1994-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0630254-A1 |
| titleOfInvention | Method of ophthalmic drug delivery |
| abstract | The invention relates to a method for prolonging the administration of a therapeutic agent into the eye. The method involves adding a desired drug to a suitable, preferably non-aqueous, excipient. A quantity of the excipient containing the therapeutic dose of the drug is placed on the skin outside the ocular surface, near the lateral and lower edges of the eyelids. The movements of the orbicularis muscle associated with those of the eyelids which close like scissors continuously transport small amounts of the therapeutic agent and the excipient in the interpalpebral sphere where the drug is released on the corneal surface. The invention also relates to an ophthalmic calcium-based composition which is particularly effective for treating dry eye syndrome and which is optimally administered by the method described. |
| priorityDate | 1992-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.